MTOR and glioblastoma: 4, 5-Dimethoxycanthin-6-one could reduce cell proliferation and cell cycle arrest, and increased cell apoptosis by targeting the LSD1 mediated AKT/mTOR and MAPK signaling pathways in glioblastoma.